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Objective: To describe the clinical and laboratory characteristics of Venom-induced 
consumption coagulopathy and to validate WBCT20 and VeMac time for bedside 
diagnosis of VICC. 
Methods: This is a prospective observational study conducted from May 2017 to August 
2018. Consecutive patients with snake bite within 24 hours with bleeding manifestations 
and/or positive WBCT20 and PT/INR above reference interval were recruited for the 
study. Variables relevant to clinical bleeding and laboratory parameters like PT/INR, 
APTT, Platelet count and Fibrinogen were assessed at 6, 12 and 24 hours after ASV. 
VeMac time (Vellore Manual activated clotting time) was performed on 37 cases and 29 
snake bite controls at 0 and 6 hours after ASV along with WBCT20.  
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Results:  A total of 37 patients were recruited. 73% of snake bites had a clinical 
syndrome consistent with Russell’s viper envenomation with haemotoxicity and AKI and 
or/neurotoxicity and the remaining had pure haemotoxicity. Three profiles of VICC were 
identified- pure VICC in 24 patients (64.9 %), VICC with thrombocytopenia in 5(13.5 %) 
and VICC with thrombocytopenia and thrombotic microangiopathy in 8(21.6 %). 
All the patients with VICC with thrombocytopenia/TMA had a syndrome suggestive of 
Russell’s viper envenomation (haemotoxicity with AKI and /or neurotoxicity).  All cases 
of pure haemotoxicity syndrome had pure VICC.   There was a significant association of 
the VICC profile to the envenomation syndrome (p<0.001). 16 (43.2%) patients had 
major bleeding -haematuria, haemetemesis, haematochezia and malena. The average 
ASV requirement was 18±7. Average time required for normalization of coagulation 
parameters was 13±9 hours. 6 patients required product transfusion, indication being 
anaemia with TMA in 4 out of 6 cases. Only 1 patient had coagulopathy not responsive to 
ASV and blood products- refractory VICC. In the comparison of VICC-
thrombocytopenia/TMA with pure VICC, those with TMA had higher rates of clinical 
bleeding (61.5% vs 41.7%), longer average time to normalization of PT/INR (15 hours to 
12 hours), greater requirement of blood products (35.8% vs 4.2%), and longer mean 
duration of hospitalization (10 days vs 5 days). In cases with syndrome typical of 
Russell’s viper, there was clinically significant bleeding despite ASV and correction of 
coagulation parameters. All patients had a good outcome.  
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We obtained a sensitivity of 93.78% and specificity of 96.55% for VeMac time of 240 
seconds at admission. The sensitivity of WBCT20 for diagnosis of VICC was 81.1% (CI 
64.84% to 92.04%) and specificity 89.7% (CI 72.65% to 97.81%). A sensitivity of 
81.82% with specificity of 47.73% was obtained at 6 hours after ASV for VeMac time of 
180 seconds. WBCT20 at 6 hours had a sensitivity of 31.8% (CI 13.9% -54.9%) and 
specificity 93.2% (81.3% -98.6%).  Overall, the performance of VeMac time was 
superior to WBCT20.  
Conclusion: 
Bleeding diathesis of Russell’s viper bite is multifactorial due to a combination of VICC, 
thrombocytopenia and probable endothelial injury. Clinical refractoriness to ASV therapy 
is probably due to the endothelial injury and closely related to the pathogenesis of TMA. 
VeMac test may be a useful bedside diagnostic test for VICC. 
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